Novartis Investigative Site

Kursk 305035

0 studies enrolling now · 3 studies all time

What they study most

Cardiovascular Disease and Lipoprotein(a), Chronic Heart Failure, Neoplasms, Gastrointestinal Tract

Studies at this site

• LOGiC - Lapatinib Optimization Study in ErbB2 (HER2) Positive Gastric Cancer: A Phase III Global, Blinded Study Designed to Evaluate Clinical Endpoints and Safety of Chemotherapy Plus Lapatinib — Completed
• Lipoprotein(a) in Patients With Cardiovascular Disease (CVD) — Completed
• Efficacy and Safety of Aliskiren and Aliskiren/Enalapril Combination on Morbidity-mortality in Patients With Chronic Heart Failure — Completed